The effect of Dexmedetomidin on controlled analgesia and hemodynamics after hip arthroplasty in elderly patients

He-lin ZENG,Jin LIU
DOI: https://doi.org/10.12037/YXQY.2017.10-36
2017-01-01
Abstract:Objective To investigate the effect of Dexmedetomidin on controlled analgesia and hemodyn-amics after hip arthroplasty in elderly patients. Method 137 elderly patients who underwent unilateral hip arthroplasty in our hospital from January 2016 to April 2017 were randomly divided into group A (31 cases), group B1 (36 cases), group B2 (33 cases) and group B3 (37 cases). All patients were given intravenous analgesia pump immediately after operation, group A were given Sufentanil combined with Granisetron; group B1 were given 0.5 μg/(kg?h) Dexmedetomidine, Sufentanil and Granisetron, group B2 were given 0.75 μg/(kg?h) Dexmedetomidine, Sufentanil and Granisetron; group B3 were given 1 μg/(kg?h) Dexmedetomidine, Sufentanil and Granisetron. The pain, hemodynamic parameters, the times of pressing patient controlled analgesia (PCA), the dosage of Sufentanil and the incidence of adverse reactions were compared among the three groups at different time points after operation. Result After operation for 1 hour and 48 hours, there were no significant differences in visual analogue scale (VAS) scores between group B1 and group A (P>0.05), and the VAS scores in group B1, B2 and B3 were significantly lower than group A at the other time points (P < 0.05), and the VAS scores in group B3 was lower than group A, group B1 and group B2 at all time points after operation (P < 0.05). After operation for 4 and 12 hours, the heart rate, systolic blood pressure and diastolic blood pressure in group B1 were significantly lower than group A (P < 0.05), the heart rate, systolic blood pressure and diastolic blood pressure in group B2 and B3 were significantly lower than group A at all time points after operation (P<0.05). The times of PCA pressing and Sufentanil dose in group B1, B2 and B3 were significantly lower than group A (P<0.05), the number of PCA press and Sufentanil in group B3 group was the least (P<0.05). There were no adverse reactions in group B2 and group B3. Conclusion Dexmedetomidine can significantly improve the postoperative analgesia effect of Sufentanil in elderly patients who undergoing hip arthroplasty, reduce the dosage of Sufentanil and the incidence of adverse reactions after operation, and help stabilize hemodynamics of patients after operation, which is worthy of clinical promotion.
What problem does this paper attempt to address?